Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Controlled therapeutic trial in IgA glomerulonephritis]

N Belovezhdov, R Robeva

    Vutreshni Bolesti
    |January 1, 1982
    PubMed
    Summary

    Indomethacin and levamisole treatments did not alter IgA glomerulonephritis progression. Combined immunosuppressive and anticoagulant therapy also failed to improve outcomes in patients with advanced renal insufficiency.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    PREVALENCE AND CHARACTERISTICS OF THE POLYCYSTIC OVARIAN SYNDROME IN OVERWEIGHT AND OBESE PREMENOPAUSAL WOMEN.

    Acta endocrinologica (Bucharest, Romania : 2005)·2023
    Same author

    A 40-YEAR FOLLOW-UP OF A PATIENT WITH MULTIPLE PARAGANGLIOMAS AND A SDHD MUTATION.

    Acta endocrinologica (Bucharest, Romania : 2005)·2019
    Same author

    Inherited Thrombophilias Could Influence the Reproductive Outcome in Women with Systemic Lupus Erythematosus.

    Balkan journal of medical genetics : BJMG·2017
    Same author

    Melatonin receptor 1b polymorphisms in women with Systemic Lupus Erythematosus.

    Acta reumatologica portuguesa·2016
    Same author

    [PAL-1 5G/4G polymorphism in patients with systemic lupus erythematosus].

    Akusherstvo i ginekologiia·2015
    Same author

    Anti-Müllerian hormone in women with polycystic ovary syndrome before and after therapy with metformin.

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2011

    Area of Science:

    • Nephrology
    • Immunology
    • Pharmacology

    Background:

    • IgA glomerulonephritis (IgAN) is a common primary glomerulonephritis.
    • Histological variations in IgAN range from minimal changes to diffuse proliferative disease.
    • Optimal therapeutic strategies for IgAN remain under investigation.

    Purpose of the Study:

    • To evaluate the efficacy of indomethacin and levamisole in IgAN.
    • To assess the impact of combined immunosuppressive and anticoagulant therapy on IgAN with renal insufficiency.

    Main Methods:

    • Controlled therapeutic study involving 38 IgA glomerulonephritis patients.
    • Patients categorized by light microscopy: minimal, focal-segmental, or diffuse glomerulonephritis.
    • Treatment groups: indomethacin, levamisole, control (no treatment), and combined therapy.

    Main Results:

    • Indomethacin and levamisole showed no significant effect on clinical manifestations or disease course.
    • No discrepancies in clinical or laboratory data were observed among the initial three groups.
    • Combined immunosuppressive and anticoagulant treatment did not halt the progression of terminal renal insufficiency.

    Conclusions:

    • Indomethacin and levamisole are ineffective for treating IgA glomerulonephritis.
    • Current combined immunosuppressive and anticoagulant regimens do not prevent the progression of renal insufficiency in advanced IgAN.

    Related Experiment Videos